We speculated that the therapeutic effect on the treatment of RA by QHSSD may be focused on antiangiogenesis, meanwhile, anti-inflammation, especially TP53 and VEGFA targets, plays a vital role during the treatment. Here, VEGFA is linked to rheumatoid arthritis.